Skip to Main Content
Frequently Asked Questions
Submit an ETD
Global Search Box
Need Help?
Keyword Search
Participating Institutions
Advanced Search
School Logo
Files
File List
akron1280335303.pdf (15.18 MB)
ETD Abstract Container
Abstract Header
Biodegradable Nanoparticles for Use as an Inhalable Antimicrobial and as a Receptor Targeted Delivery Device
Author Info
Ditto, Andrew James
Permalink:
http://rave.ohiolink.edu/etdc/view?acc_num=akron1280335303
Abstract Details
Year and Degree
2010, Doctor of Philosophy, University of Akron, Biomedical Engineering.
Abstract
Drug delivery challenges include drug instability, insolubility, dosing, toxicity, and targeting, which can be addressed by encapsulation into degradable nanoparticles that can be modified for numerous applications. Previous studies have demonstrated the synthesis and characterization of degradable nanoparticles formulated form L-tyrosine polyphosphate (LTP) that show promise for a wide array of drug delivery applications. One such application is inhalable antimicrobials to chronically infected lungs of cystic fibrosis patients, which currently suffer from fast clearance, poor stability, and resistance. An additional application is receptor targeted anticancer drug delivery, since current anticancer agents, such as cisplatin, may cause nonspecific toxicity. Therefore, we have produced and characterized nanoparticles formulated primarily from LTP that can be modified for use as an inhalable antimicrobial loaded with silver carbene complexes (SCC), or as a receptor targeted delivery system decorated with folic acid. Dynamic light scattering shows diameter ranges around 1 µm that is optimal for inhalable delivery, or approximately 200 nm that is optimal for anticancer drug endocytosis. SCC’s are release over 7 days in vitro from LTP nanoparticles. Furthermore, degrading LTP nanoparticles do not lower the pH unlike poly(lactic-co-glycolic acid) (PLGA) nanoparticles that lower the pH to acidic levels. This lack of acidic degradation products results in low fibroblast toxicity comparable to PLGA nanoparticles and buffers as shown by MTT and LIVE/DEAD assays. These toxicity assays also reveal mean lethal dosage values less than minimum inhibitory concentrations from clinically relevant in vitro planktonic and biofilm antibacterial assays. This antibacterial efficacy is reflected with an in vivo mouse model, in which SCC-LTP nanoparticles achieve a 100% survival advantage. Furthermore, folic acid decoration of LTP nanoparticles demonstrates a receptor mediated targeting with a 10-fold greater attachment to HeLa cancer cells under simulated physiological flow compared to undecorated nanoparticles and non-cancerous fibroblasts. This attachment is inhibited with excess folic acid in the perfusion solution. A 30 minute incubation and LIVE/DEAD assay show these folic acid decorated nanoparticles loaded with SCC’s have increased anticancer efficacy compared to drug alone. Thus, LTP nanoparticles can be utilized for a wide array of drug delivery applications including inhalable antimicrobials or receptor targeted anticancer drug delivery.
Committee
Yang Yun, Dr. (Advisor)
Pages
245 p.
Subject Headings
Biomedical Research
Keywords
nanoparticles
;
drug delivery
;
antimicrobial
;
targeted
;
targeting
;
folic acid
;
L-tyrosine
;
degradable
;
sustained release
;
silver
;
SCC
;
LTP
Recommended Citations
Refworks
EndNote
RIS
Mendeley
Citations
Ditto, A. J. (2010).
Biodegradable Nanoparticles for Use as an Inhalable Antimicrobial and as a Receptor Targeted Delivery Device
[Doctoral dissertation, University of Akron]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=akron1280335303
APA Style (7th edition)
Ditto, Andrew.
Biodegradable Nanoparticles for Use as an Inhalable Antimicrobial and as a Receptor Targeted Delivery Device.
2010. University of Akron, Doctoral dissertation.
OhioLINK Electronic Theses and Dissertations Center
, http://rave.ohiolink.edu/etdc/view?acc_num=akron1280335303.
MLA Style (8th edition)
Ditto, Andrew. "Biodegradable Nanoparticles for Use as an Inhalable Antimicrobial and as a Receptor Targeted Delivery Device." Doctoral dissertation, University of Akron, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=akron1280335303
Chicago Manual of Style (17th edition)
Abstract Footer
Document number:
akron1280335303
Download Count:
1,868
Copyright Info
© 2010, all rights reserved.
This open access ETD is published by University of Akron and OhioLINK.